This patent covers the composition of matter for several aminocarboxylic acid amide derivatives that are both immunostimulatory, as well as augment hematopoietic activity of stem cells. This seems very interesting a combination since many cytokines that stimulate the immune system, at least the Th1 arm of the immune system, are also suppressive to the hematopoietic compartment.
For example, interferon gamma is a potent Th1 cytokine but causes myelosuppression when expressed locally.
This patent is definatly worth while for entry into clinical development.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.